Jack A. Khattar
2020
Compensation breakdown
Non-Equity Incentive Plan | $815,500 |
---|---|
Option Awards | $3,955,883 |
Salary | $836,400 |
Stock Awards | $1,032,813 |
Other | $28,451 |
Total | $6,669,046 |
Khattar received $4M in option awards, accounting for 59% of the total pay in 2020.
Khattar also received $815.5K in non-equity incentive plan, $836.4K in salary, $1M in stock awards and $28.5K in other compensation.
Rankings
In 2020, Jack A. Khattar's compensation ranked 1,500th out of 13,090 executives tracked by ExecPay. In other words, Khattar earned more than 88.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,500 | 89th |
Manufacturing | 562 | 90th |
Chemicals And Allied Products | 203 | 91st |
Drugs | 169 | 91st |
Pharmaceutical Preparations | 117 | 92nd |
Pay ratio
Jack A. Khattar's Pay | $6,669,046 |
---|---|
Median Employee's Pay | $148,804 |
Pay Ratio | 45to 1 |
In 2020, the annual total compensation of Jack A. Khattar was $6,669,046.
The annual total compensation of the median employee at Supernus Pharmaceuticals was $148,804.
The ratio of Jack A. Khattar's pay to the pay of median employee was therefore 45 to one.
Khattar's colleagues
We found five more compensation records of executives who worked with Jack A. Khattar at Supernus Pharmaceuticals in 2020.
2020
James Kelly
Supernus Pharmaceuticals
Chief Financial Officer
2020
Stefan Schwabe
Supernus Pharmaceuticals
Chief Medical Officer
2020
Gregory Patrick
Supernus Pharmaceuticals
Chief Financial Officer
2020
Padmanabh Bhatt
Supernus Pharmaceuticals
Chief Scientific Officer
2020
Tami RN
Supernus Pharmaceuticals